share_log

Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Huntsman Ronald Kirk

SEC announcement ·  Jun 20, 2023 06:10
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more